OncoFactory laureate of the 2nd Lyonbiopôle / HCL Clinical Innovation Call

OncoFactory laureate of the 2nd Lyonbiopôle / HCL Clinical Innovation Call

 

The Melano Predict project, led by OncoFactory and Professor Stéphane Dalle, a dermatologist specializing in melanomas, is the winner of the 2nd Lyonbiopôle / HCL Clinical Innovation Call.

“With the Melano Predict project, OncoFactory will develop biomarkers that will help practitioners in their therapeutic choice and thus improve the management of patients with metastatic melanoma” says Frédéric Berget, President of OncoFactory.

The project will benefit from advice and operational support from HCL, as well as financial support up to 100,000 euros. This support will help the development of technology and, in the longer term, optimize access to the public order and make it available to patients.